ENSYSCE BIOSCIENCES, INC. Other Non-Current Assets
ENSYSCE BIOSCIENCES, INC. (ENSC) had Other Non-Current Assets of $41.67 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-13
- 2026-03-31: Other Assets, Noncurrent $41.67K.
- 2025-12-31: Other Assets, Noncurrent $83.33K; Other Assets, Noncurrent as first filed $85.88K.
- 2025-09-30: Other Assets, Noncurrent $127.55K.
- 2025-06-30: Other Assets, Noncurrent $292.86K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-03-31 | $41.67K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $83.33K 10-Q · filed 2026-08-13 | $85.88K 10-K · filed 2026-03-30 |
| 2025-09-30 | $127.55K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $292.86K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $210.88K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $252.55K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $294.22K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $335.88K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $377.55K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $419.22K 10-K · filed 2025-03-10 | |
| 2023-09-30 | $460.88K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $502.55K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $544.22K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $585.88K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $627.55K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $671.42K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $713.09K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $754.76K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $796.42K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $838.09K 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $3.78K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |